Ryan J. MacKenzie - Concepedia

Author

Ryan J. MacKenzie

Also Known As

R J MacKenzie, R MacKenzie, Ryan J. MacKenzie, Ryan J. Mackenzie, Ryan MacKenzie, Ryan Mackenzie

Publications

395

Citations

H-Index

Concepts

All Affiliations

Ryan J. MacKenzie is an author at Oregon Health & Science University specializing in gene expression, cell biology, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	11
2	Cell Biology	1	1	11
3	Immunology	1	1	11
4	Cell Signaling	1	1	11
5	Gene Expression	1	1	11

Ryan J. MacKenzie

Publications

244

Citations

H-Index

Page 1

	Year	Citations
Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia Anupriya Agarwal, Ryan J. MacKenzie, Raffaella Pippa, Clinical Cancer Research	2014	123
Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML Anupriya Agarwal, Angela G. Fleischman, Curtis L. Petersen, Blood	2012	41
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein Anupriya Agarwal, Ryan J. MacKenzie, Arnaud Besson, Blood	2014	28
Threshold Levels of ABL Tyrosine Kinase Inhibitors Retained in Chronic Myeloid Leukemia Cells Determine Their Commitment to Apoptosis Thomas O’Hare, Christopher A. Eide, Anupriya Agarwal, Cancer Research	2013	27
A Novel SET Antagonist (OP449) Is Cytotoxic to CML Cells, Including the Highly-Resistant BCR-ABLT315I Mutant, and Demonstrates Enhanced Efficacy in Combination with ABL Tyrosine Kinase Inhibitors, Anupriya Agarwal, Ryan J. MacKenzie, Jessica Oddo, Blood	2011	14
Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia Anupriya Agarwal, Ryan J. MacKenzie, Christopher A. Eide, Oncogene Growth Factor ReceptorsCytokineSignal TransductionSignaling PathwayMedicine	2014	11

Page 1